Skip to main content

Table 1 Demographic, clinical, and biochemical characteristics of the subjects

From: Serum progranulin/tumor necrosis factor-α ratio as independent predictor of systolic blood pressure in overweight hypertensive patients: a cross-sectional study

Parameters Group I
(control)
(n = 25)
Group II
(SDH patients)
(n = 25)
Group III
(ISH patients)
(n = 25)
p
Male/female number 11/14 15/10 12/13  
AGE (years) 56.00 ± 8.55 52.95 ± 12.61 55.80 ± 9.40 0.55
BMI (kg/m2) 25.35 ± 6.92 28.12 ± 6.52 27.37 ± 5.32 0.28
SBP (mmHg) 121.36 ± 5.15 161.75 ± 15.49 168.68 ± 7.17 < 0.001*
DBP (mmHg) 82.36 ± 3.63 102.50 ± 5.50 89.20 ± 2.55 < 0.001*
PP (mmHg) 39.00 ± 5.90 59.25 ± 13.40 79.48 ± 7.14 < 0.001*
Progranulin (ng/ml) 50.10 ± 4.70 71.36 ± 18.36 82.31 ± 16.32 < 0.001*
0.009^
TNF-α (pg/ml) 3.57 ± 1.90 19.68 ± 5.19 21.07 ± 6.32 < 0.001*
0.31^
PGRN/TNF-α ratio 23.98 ± 7.44 3.79 ± 1.33 4.32 ± 1.80 < 0.01*
0.67^
  1. BMI body mass index, SBP systolic blood pressure, DBP diastolic blood pressure, TNF-α tumor necrosis factor alpha, PGRN progranulin. Results are expressed as mean ± SD; p significant at < 0.05 (*p value: patients vs. control; ^p value SDH patients vs. ISH patients)